FindTrial
Sign In

Medical Cannabis

DRUG16 trials

Sponsors

University of Colorado, Denver, The Epilepsy Research Program of the Ontario Brain Institute, Cannabis Research Associates, HaEmek Medical Center, Israel, University Health Network, Toronto

Conditions

Agitation,PsychomotorAlzheimer DiseaseAnxietyBladder, OveractiveCancerCannabisCannabis UseChemotherapy-induced Peripheral Neuropathy

Phase 2

A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
CompletedNCT06490445
Syqe MedicalDiabetic Peripheral Neuropathic Pain
Start: 2024-11-14End: 2026-06-24Updated: 2026-06-29
A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients
RecruitingNCT06518434
University Medical Center GroningenCannabis, Hepatocellular Carcinoma
Start: 2021-04-15End: 2027-04-15Target: 20Updated: 2024-07-24
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
RecruitingNCT06605430
HealthPartners InstituteColorectal Cancer Metastatic, Pancreatic Cancer Metastatic, Pancreatic Cancer Non-resectable
Start: 2024-09-16End: 2026-12-31Target: 64Updated: 2025-07-29

Phase 3

Cannabis Extract in Refractory Epilepsy Study
TerminatedNCT03808935
The Epilepsy Research Program of the Ontario Brain InstituteDrug Resistant Epilepsy
Start: 2019-01-10End: 2020-03-15Updated: 2020-09-11

Unknown Phase

The Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy
NCT02523183
University of Colorado, DenverEpilepsy, Unspecified, Refractory (Medically)
Start: 2015-07-31End: 2020-11-30Target: 150Updated: 2020-01-18
Cannabis for Opioid Substitution Trial
NCT03859089
Cannabis Research AssociatesCannabis Use, Opioid Use, Pain Syndrome
Start: 2017-10-10End: 2019-10-31Target: 1200Updated: 2019-03-01
The Kinetics of Endocannabinoids in Patients With Chemotherapy Induced Peripheral Neuropathy by Using Medical Cannabis.
NCT04376437
HaEmek Medical Center, IsraelChemotherapy-induced Peripheral Neuropathy
Start: 2022-03-15End: 2023-12-01Target: 40Updated: 2022-03-16
Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
RecruitingNCT04526093
University Health Network, TorontoAnxiety, Depression, Epilepsy +2
Start: 2020-07-15End: 2028-07-01Target: 1000Updated: 2026-07-22
Reactions of Older Adults Driving After Cannabis Exposure
CompletedNCT04629716
Florida State UniversityChronic Pain
Start: 2021-04-23End: 2023-08-31Updated: 2025-03-24
Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's Disease
NCT05106504
Sheba Medical CenterBladder, Overactive, Parkinson Disease
Start: 2021-09-02End: 2024-08-31Target: 100Updated: 2021-11-03
The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette Syndrome
CompletedNCT05115318
Tel-Aviv Sourasky Medical CenterCannabis, Tourette Syndrome
Start: 2020-07-01End: 2021-03-31Updated: 2021-11-10
Inflammatory Bowel Diseases (IBD) Cannabis Registry
NCT05578313
Eli Sprecher, MDCrohn Disease, Healthy, Pouchitis +1
Start: 2019-07-10End: 2024-07-10Target: 1000Updated: 2022-10-13
Real World Evidence on the Use of Medical Cannabis in Pediatrics
RecruitingNCT05863910
University of ManitobaCancer, Epilepsy, Neurodevelopmental Disorders
Start: 2023-11-20End: 2027-12-31Target: 500Updated: 2023-11-30
Can Medical Cannabis Affect Opioid Use?
CompletedNCT06206252
Thomas Jefferson UniversityChronic Pain, Pain
Start: 2023-09-07End: 2025-12-02Updated: 2026-09-03
A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.
TerminatedNCT06217146
M. H MediCane Ltd.Agitation,Psychomotor, Alzheimer Disease, Dementia +1
Start: 2022-10-12End: 2024-03-10Updated: 2024-06-27
Medical Cannabis Observational Study for Antiemetic Intervention in Chemotherapy
Not yet recruitingNCT07374939
University of RochesterNausea and Vomiting Chemotherapy-Induced
Start: 2026-09-01End: 2028-03-01Target: 50Updated: 2026-06-09

Related Papers

A randomized phase II trial of medical cannabis to reduce symptom burden in patients with newly diagnosed advanced pancreatic cancer (CanPan).
Journal of Clinical Oncology2026-01-10
A randomized phase II trial of medical cannabis to reduce symptom burden in patients with newly diagnosed advanced colorectal cancer (CANCOL).
Journal of Clinical Oncology2026-01-10
A multi-centre, tolerability study of a cannabidiol-enriched Cannabis Herbal Extract for chronic headaches in adolescents: The CAN-CHA protocol
PLoS ONE2024-09-201 citations